Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
Peter Ammann, MD*,*,1,
Marco Maggiorini, MD ,
Osmund Bertel, MD*,
Edgar Haenseler, MD ,
Helen I. Joller-Jemelka, MD||,
Erwin Oechslin, MD¶,
Elisabeth I. Minder, MD ,
Hans Rickli, MD¶ and
Thomas Fehr, MD
* Division of Cardiology, Triemli Hospital, Zurich, Switzerland
Central Laboratory, Triemli Hospital, Zurich, Switzerland
Intensive Care Unit of the Department of Internal Medicine, Zurich, Switzerland
Institute of Clinical Chemistry, Zurich, Switzerland
|| Division of Clinical Immunology, University Hospital, Zurich, Switzerland
¶ Division of Cardiology, University Hospital, Zurich, Switzerland

View larger version (27K):
[in a new window]
|
Figure 1 Kaplan-Meier survival analysis of troponin-positive and -negative patients. (A) The overall 30-day mortality was significantly higher in troponin-positive (n = 32) than in troponin-negative (n = 26) patients (p = 0.018). (B) When subgroups of patients with volume-refractory shock needing catecholamine therapy (n = 24) and patients without shock (n = 34) were analyzed separately, a significant difference in mortality was found in the subgroup without shock only (p = 0.03). ns = not significant.
|
|

View larger version (21K):
[in a new window]
|
Figure 2 Relationship between left ventricular ejection fraction (LVEF) and peak cardiac troponin I (cTnI) level. A significantly lower LVEF was found in troponin-positive versus -negative patients (r = 0.44, p = 0.0006). All patients with LVEF <45% (left of thin vertical line) had sepsis or septic shock, and 11 of 13 were troponin-positive. The normal cutoff level for cTnI is indicated at 0.1 µg/l by a bold horizontal line.
|
|
|